Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose
Venkatakrishnan, Karthik, Kim, Tae Min, Lin, Chia-Chi, Thye, Lim Soon, Chng, Wee Joo, Ma, Brigette, Chen, Ming Huang, Zhou, Xiaofei, Liu, Hua, Kelly, Virginia, Kim, Won SeogVolume:
33
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-015-0258-y
Date:
August, 2015
File:
PDF, 468 KB
english, 2015